Respiratory Syncytial Virus (RSV) - Canary in the Coal Mine?
From here:
RSV National Trends - NREVSS | CDC
https://www.cdc.gov/surveillance/nrevss/rsv/natl-trend.html
No doubt the CDC give us a breakdown between unvaxxed, single vaxxed, double vaxxed and single/double boosted if it wanted - without the usual 14 day lag for each injection to “take effect”.
You never know, maybe it is also using Focus-Forming Assays rather than RNA to determine infectiousness below RT-PCR amplification cycles of 27, as in this article here:
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Nature Medicine
https://www.nature.com/articles/s41591-022-01816-0
Be good to get an update of that article in Nature Medicine!
https://childrenshealthdefense.org/defender/pfizer-fast-track-vaccines-pregnant-moms/
On Nov. 1, Pfizer issued a press release about an investigational vaccine for pregnant women the company said will protect babies from respiratory syncytial virus (RSV).
Not coincidentally, RSV is the latest viral bugaboo to hit the headlines, with frantic news accounts of “overwhelmed” hospitals sounding eerily reminiscent of the early coronavirus fear-mongering.